On November 22, 2021 OncoResponse, a clinical-stage biotech company advancing immunotherapies derived from the immune systems of elite cancer responders, reported that Clifford Stocks, Chief Executive Officer, will participate in two upcoming investor conferences (Press release, OncoResponse, NOV 22, 2021, View Source [SID1234595936]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Presentation details are as follows:

Piper Sandler 33rd Annual Virtual Healthcare Conference

Format: Corporate Presentation;1X1 investor meetings
Time/Date: Presentation will be available beginning Nov. 22, 2021, at 10 a.m. Eastern.

RBC Capital Markets Healthcare Private Company Conference

Format: Fireside chat with analyst-moderated Q&A; 1X1 investor meetings
Time/Date: Thursday, December 16, 2021, at 3:50 p.m. Eastern.

Both presentations will be accessible from the News Center / Events & Presentations page of the OncoResponse website and available for at least 30 days.